Sign in

CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company

Annovis Bio, Inc.

Sign in to watch
Ticker
ANVS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262540421
Phone
484-875-3192
Business address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
Former names
QR Pharma, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 8-K Event Other events
  3. 10-K Report Annual Report
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 8-K Event Bylaws or fiscal year change
  6. 4 Open-market buy Director bought 33,333 shares at $6.00 ($199,998)
  7. 4 Open-market buy Director bought 25,000 shares at $6.00 ($150,000)
  8. 4 Open-market buy Director bought 800 shares at $6.00 ($4,800)
  9. 4 Open-market buy President and CEO bought 1,600 shares at $6.00 ($9,600)
  10. 4 Open-market buy Chief Financial Officer bought 52,833 shares at an average $6.42 ($339,426)
  11. 4 Open-market buy Director bought 1,734 shares at $6.00 ($10,404)
  12. SC 13G Stake Amended Statement of Ownership
  13. 424B4 Offering Prospectus
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. S-1MEF Other S-1MEF

Page 14 of 16 · 315 filings